Table 2 CMR infarct heterogeneity measurements in subjects with and without ICD therapy
|  | With ICD therapy (n = 12) | Without ICD therapy (n = 13) | P value | |||
|---|---|---|---|---|---|---|
MCLE | IR-FGRE | MCLE | IR-FGRE | MCLE | IR-FGRE | |
GZ/LVM (%) | 14.8 ± 4.8 | 13.8 ± 5.1 | 11.2 ± 3.9 | 10.6 ± 5.1 | 0.046 | 0.14 |
Core MI/LVM (%) | 25.8 ± 10.9 | 22.4 ± 9.9 | 19.6 ± 10.1 | 16.8 ± 10.9 | 0.15 | 0.19 |
Total MI/LVM (%) | 40.6 ± 13.5 | 36.2 ± 14.8 | 30.9 ± 13.5 | 27.4 ± 15.8 | 0.08 | 0.16 |